Mayfair Advisory Group
CVS icon

Mayfair Advisory Group’s CVS Health CVS Stock Holding History

Mayfair Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,009
Closed -$216K – 188
2026
Q2 		$216K Buy
+2,009
New +$179K 0.07% 176
2023
Q2 		– Sell
-2,785
Closed -$208K – 128
2023
Q1 		$208K Buy
+2,785
New +$234K 0.23% 109
2022
Q4 		– Sell
-2,494
Closed -$244K – 117
2022
Q3 		$244K Buy
+2,494
New +$247K 0.34% 86

Other funds holding CVS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Mayfair Advisory Group's CVS Position: Q3 2026 in Review

Mayfair Advisory Group sold out of CVS Health (CVS) in Q3 2026, closing a stake of 2,009 shares — an estimated $216K sold.

Mayfair Advisory Group first reported a position in CVS in Q3 2022 and held it in 3 quarters. The position peaked at $244K in Q3 2022. 1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Mayfair Advisory Group reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • Mayfair Advisory Group sold 2,009 CVS Health shares in Q3 2026, an estimated $216K.
  • Mayfair Advisory Group first reported a position in CVS Health in Q3 2022 and held it in 3 quarters.
  • Mayfair Advisory Group's CVS Health position peaked at $244K in Q3 2022.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Mayfair Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.